Composite measures in psoriatic arthritis: GRAPPA 2008

Area of Science:

• Rheumatology
• Clinical Assessment

Background:

• Psoriatic arthritis (PsA) assessment currently lacks a comprehensive composite measure.
• Existing composite measures for rheumatoid arthritis (RA) and ankylosing spondylitis (AS) were reviewed.
• Recent composite methods for PsA assessment were presented.

Purpose of the Study:

• To discuss the need for and current status of composite measures in psoriatic arthritis (PsA).
• To identify essential components for a new, specific PsA composite assessment tool.

Main Methods:

• Review of composite measures from related rheumatic diseases (RA, AS) and systemic lupus erythematosus.
• Presentation and discussion of recently developed PsA composite assessment methods.
• Breakout group discussions among GRAPPA members.

Main Results:

• Consensus reached on the necessity of a novel composite measure tailored for PsA.
• Agreement that the new measure must address the full spectrum of PsA manifestations.
• Key components identified: peripheral joints, sacroiliitis, spondylitis, enthesitis, dactylitis, skin, and nail disease.

Conclusions:

• A dedicated composite measure for psoriatic arthritis is essential for accurate assessment.
• Future composite measures should integrate peripheral, axial, and dermatological aspects of PsA.
• Development of such a measure will improve disease management and research in PsA.